KCM
SZYM

Kingdon Capital Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Kingdon Capital Management’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-121,850
Closed -$1.31M – 236
2013
Q3 		$1.31M Hold
121,850
– – 0.06% 171
2013
Q2 		$1.42M Buy
+121,850
New +$1.22M 0.08% 176

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kingdon Capital Management's SZYM Position: Q4 2013 in Review

Kingdon Capital Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q4 2013, closing a stake of 121,850 shares — an estimated $1.31M sold.

Kingdon Capital Management first reported a position in SZYM in Q2 2013 and held it in 2 quarters. The position peaked at $1.42M in Q2 2013. 105 funds tracked by Wall St. Rank hold SZYM as of Q4 2013.

  • Kingdon Capital Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q4 2013 after selling out during the quarter.
  • Kingdon Capital Management sold 121,850 SOLAZYME INC COM STK (DE) shares in Q4 2013, an estimated $1.31M.
  • Kingdon Capital Management first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 2 quarters.
  • Kingdon Capital Management's SOLAZYME INC COM STK (DE) position peaked at $1.42M in Q2 2013.
  • 105 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q4 2013.

Based on Kingdon Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.